Provided by Tiger Trade Technology Pte. Ltd.

Hims & Hers Health Inc.

23.15
-1.8300-7.33%
Pre-market: 22.80-0.3500-1.51%06:13 EDT
Volume:35.35M
Turnover:846.19M
Market Cap:5.27B
PE:45.19
High:25.04
Open:24.70
Low:23.15
Close:24.98
52wk High:70.43
52wk Low:13.74
Shares:227.65M
Float Shares:197.51M
Volume Ratio:0.60
T/O Rate:17.90%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.5123
EPS(LYR):0.5123
ROE:25.23%
ROA:5.29%
PB:9.74
PE(LYR):45.19

Loading ...

Unusually active option classes on open March 9th

TIPRANKS
·
Mar 09

Hims, Novo Nordisk Bound by Mutual Necessity -- Market Talk

Dow Jones
·
Mar 09

BUZZ-U.S. STOCKS ON THE MOVE-Hims & Hers, Live Nation, NovaBridge

Reuters
·
Mar 09

Video: Hims & Hers surges after weight loss drug pact with Novo Nordisk

TIPRANKS
·
Mar 09

Hims shares jump on deal to offer Novo's Wegovy, Ozempic on its platform

Reuters
·
Mar 09

BRIEF-FDA's Makary Says Glad To See Hims Will Stop Advertising Unapproved Compounded Drugs

Reuters
·
Mar 09

FDA's Makary: Glad to See Hims Will Stop Advertising Unapproved Compounded Drugs, Instead Sell FDA-Approved Products Through New Partnership With Novo

THOMSON REUTERS
·
Mar 09

Hims Could See Near-Term Headwinds From Novo Partnership -- Market Talk

Dow Jones
·
Mar 09

Last up 55.1% Premarket

THOMSON REUTERS
·
Mar 09

Hims & Hers' Shares Extend Gains After Novo Nordisk Strikes Deal for Co to Sell Wegovy and Ozempic, Drops Lawsuit

THOMSON REUTERS
·
Mar 09

Hims & Hers Health Inc - Announces Collaboration With Novo Nordisk for US Glp-1 Weight Loss Strategy

THOMSON REUTERS
·
Mar 09

Novo Nordisk: Dismissing Patent Infringement Lawsuit Against Hims & Hers While Reserving Right to Refile in Future

THOMSON REUTERS
·
Mar 09

Novo Nordisk: Hims & Hers to No Longer Advertise Compounded Glp-1 Offerings on Its Platform or in Its Marketing

THOMSON REUTERS
·
Mar 09

Novo Nordisk: Under Deal, Hims & Hers to Give Access to Ozempic Injection, Wegovy Pill & Injection to U.S. Consumers at Self-Pay Prices

THOMSON REUTERS
·
Mar 09

Novo Nordisk: Reached Agreement With Hims & Hers That Will Take Effect Later This Month

THOMSON REUTERS
·
Mar 09

Novo Nordisk strikes deal for Hims to sell Wegovy and Ozempic, drops lawsuit

Reuters
·
Mar 09

Hims & Hers: Plans to Offer Access to Compounded Glp-1S IF Provider Decides Compounded Product Is Clinically Necessary

THOMSON REUTERS
·
Mar 09

Top Premarket Gainers

MT Newswires Live
·
Mar 09

Analysts Offer Insights on Healthcare Companies: Exelixis (EXEL), Hims & Hers Health (HIMS) and Regeneron (REGN)

TIPRANKS
·
Mar 09

Hims & Hers Stock Soars 54%. It's Struck a Truce With Novo Nordisk, Report Says. -- Barrons.com

Dow Jones
·
Mar 09